Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Spokane
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Spokane, WA

Studies commonly pay $75 to $4,500 per completed study

294 clinical trials are currently recruiting participants within 30 miles of Spokane. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

294studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Spokane right now

Top 25 of 294 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Spokane, Washington (0.5 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Non-Small Cell Lung Cancer (NSCLC) Phase 3 Interventional 750 participants sought
Local Institution - 0384 — Spokane, Washington (0.5 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07361510)

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Childhood Medulloblastoma Phase 3 Interventional 225 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05382338)

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Diabetic Kidney Disease, Type 1 Diabetes Phase 2 Interventional 60 participants sought
Providence Sacred Heart Medical Center — Spokane, Washington (0.5 mi) · Sponsor: University of Washington
See eligibility & contact on ClinicalTrials.gov (NCT05822609)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Spokane, Washington (0.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Phase 3 Interventional 450 participants sought
Sl0044 50061 — Spokane Valley, Washington (9.0 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT06617325)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University Telemedicine — Spokane, Washington (0.5 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Heart Failure, Acute Heart Failure Phase 3 Interventional 5,200 participants sought
Spokane, WA Investigative Site 10123 — Spokane, Washington (0.5 mi) · Sponsor: Colorado Prevention Center
See eligibility & contact on ClinicalTrials.gov (NCT06008197)

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Cystic Fibrosis N/A Observational 400 participants sought
Providence Medical Group, Cystic Fibrosis Clinic — Spokane, Washington (0.5 mi) · Sponsor: Nicole Hamblett
See eligibility & contact on ClinicalTrials.gov (NCT06504589)

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Transthyretin Amyloidosis With Cardiomyopathy Phase 3 Interventional 1,750 participants sought
Clinical Trial Site — Spokane, Washington (0.5 mi) · Sponsor: Alnylam Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07052903)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06126276)

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Chronic Kidney Disease Phase 2 Interventional 465 participants sought
Providence Medical Research Center — Spokane, Washington (0.5 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06717698)

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,524 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07200830)

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Breast Cancer, TNBC - Triple-Negative Breast Cancer N/A Observational 900 participants sought
Cancer Care Northwest — Spokane Valley, Washington (9.0 mi) · Sponsor: Tempus AI
See eligibility & contact on ClinicalTrials.gov (NCT07211178)

Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue

Skin Laxity (Submental and Neck), Facial Skin Laxity N/A Interventional 273 participants sought
Dermatology — Spokane, Washington (0.5 mi) · Sponsor: CLASSYS Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07229430)

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Alcohol Use Disorder (AUD), Nicotine Use Disorder Phase 2 Interventional 205 participants sought
Washington State University — Spokane, Washington (0.5 mi) · Sponsor: Washington State University
See eligibility & contact on ClinicalTrials.gov (NCT05181891)

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Diabetic Nephropathies, Kidney Failure, Chronic Phase 3 Interventional 150 participants sought
Providence Sacred Heart Medical Center — Spokane, Washington (0.5 mi) · Sponsor: Alessandro Doria
See eligibility & contact on ClinicalTrials.gov (NCT06217302)

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

CLL / SLL, CLL (Chronic Lymphocytic Leukemia) Phase 3 Interventional 306 participants sought
Medical Oncology Associates - Spokane — Spokane, Washington (0.5 mi) · Sponsor: Newave Pharmaceutical Inc
See eligibility & contact on ClinicalTrials.gov (NCT07342478)

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Mitral Valve Regurgitation N/A Interventional 1,056 participants sought
Providence Sacred Heart Medical Center & Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: Medtronic Cardiovascular
See eligibility & contact on ClinicalTrials.gov (NCT03242642)
Actively enrolling

Studies you may be able to join near Spokane

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Spokane

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Inland Northwest Research

★ 5.0
610 S Sherman St Ste 208, Spokane, WA 99202
(509) 960-2818

Premier Clinical Research

★ 5.0
324 S Sherman St, Spokane, WA 99202
(509) 343-3710

Providence Medical Research Center

★ 5.0
105 W 8th Ave Ste 250E, Spokane, WA 99204
(509) 474-4345
"I dont know will see after my appointment today"
— Terry A, 5★

Citta Clinical Research

251 E 5th Ave Ste a, Spokane, WA 99202
(509) 816-1819

Principle Research Solutions

510 S Cowley St, Spokane, WA 99202
(509) 474-1107

WSU Spokane Center for Clinical Research and Simulation (CCRS)

410 North Sherman Street, Spokane, WA 99202
(509) 358-7500

WSU APPL & PRISM Research Clinics

★ 5.0
225 E 3rd Ave, Spokane, WA 99202
(509) 638-2376
"The people who work there are so caring & friendly.<br>I always look forward to visiting them."
— Michael K., 5★

Strategic Research Associates

★ 3.8
29 W Pacific Ave, Spokane, WA 99201
(888) 554-6960
"I have received texts occasionally for the last 10 years that I’m “qualified” for one of their surveys/programs. I’ve filled out 20+ questionnaires t…"
— Morgan Ireland, 1★

Velocity Clinical Research

★ 5.0
9921 N Nevada St Ste 200, Spokane, WA 99218
(509) 505-6227
"The staff is always awesome as well as my experience with the clinical trials. Down 26 pounds in just a few months. Not been this weight since just …"
— Rebecca Williams, 5★

Clinical trials in Spokane: what's recruiting

The Spokane area currently has 294 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Spokane, the most active research areas are:

  • Cancer & Oncology12 studies
  • Liver & Kidney3 studies
  • Heart & Vascular3 studies
  • Diabetes & Metabolism2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Spokane, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Spokane

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Spokane participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Spokane pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Spokane?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Spokane safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Spokane, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Spokane?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Spokane.

Paid clinical trials near Spokane

Other metros within reach

Kennewick, WA54 Nampa, ID253 Boise, ID253 Bellevue, WA1,509 Marysville, WA198 Seattle, WA1,501 Tacoma, WA1,453 Bremerton, WA1,475

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Spokane Bladder Issues Due To Spinal Cord Injury in Spokane All conditions

More of WA

Bellevue1,509 Seattle1,501 Bremerton1,475 Tacoma1,453 Vancouver1,020 Olympia226 Marysville198 Kennewick54

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts